↓ Skip to main content

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
Published in
Alzheimer's Research & Therapy, November 2022
DOI 10.1186/s13195-022-01110-8
Pubmed ID
Authors

Randall J. Bateman, Jeffrey Cummings, Scott Schobel, Stephen Salloway, Bruno Vellas, Mercè Boada, Sandra E. Black, Kaj Blennow, Paulo Fontoura, Gregory Klein, Sheila Seleri Assunção, Janice Smith, Rachelle S. Doody

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 83 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 10%
Student > Ph. D. Student 5 6%
Student > Master 5 6%
Student > Bachelor 4 5%
Unspecified 3 4%
Other 12 14%
Unknown 46 55%
Readers by discipline Count As %
Neuroscience 10 12%
Biochemistry, Genetics and Molecular Biology 6 7%
Medicine and Dentistry 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Unspecified 3 4%
Other 9 11%
Unknown 46 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2022.
All research outputs
#4,275,238
of 23,243,271 outputs
Outputs from Alzheimer's Research & Therapy
#935
of 1,260 outputs
Outputs of similar age
#86,348
of 440,821 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#37
of 60 outputs
Altmetric has tracked 23,243,271 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,260 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.0. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,821 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.